GlassScriptPhysician profile
Peter H Hanna
NPI 1023465903
$12,547.35
in general payments reported to CMS, 2019-2025
43 companies · $524 in 2025
The $524 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,277 · 2020: $1,969 · 2021: $2,530 · 2022: $1,464 · 2023: $2,237 · 2024: $546 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,377 · Travel and Lodging: $595 · Long Term Medical Supply Or Device Loan: $325 · Gift: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,377.18 |
| Travel and Lodging | $594.62 |
| Long Term Medical Supply Or Device Loan | $325.00 |
| Gift | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,280.61 | 2019-2025 | Collagenase Santyl, Grafix Pl, Oasis |
| Organogenesis INC. | $2,420.04 | 2019-2025 | Puraply, Affinity |
| Medline Industries LP | $2,019.83 | 2019-2023 | |
| Osiris Therapeutics INC. | $440.96 | 2019 | |
| Integra Lifesciences Corporation | $421.46 | 2022-2023 | Integra, Tenoglide, Integra Dermal Regeneration Template |
| Melinta Therapeutics, LLC | $345.66 | 2019-2022 | |
| Bioventus LLC | $297.50 | 2021-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Polynovo North America LLC | $294.79 | 2022-2025 | Novosorb Btm |
| Abbvie INC. | $260.26 | 2023-2025 | |
| Wright Medical Technology, INC. | $248.11 | 2019 | |
| Paragon 28, INC. | $241.74 | 2020-2022 | |
| Davol INC. | $222.32 | 2020 | |
| Stryker Corporation | $205.05 | 2019-2020 | |
| Kci USA, INC. | $191.38 | 2020-2023 | Activ.A.C., Kerramax Care |
| Bone Support INC. | $140.93 | 2024 | Ceramentbone Void Filler, Cerament G |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ets Wound Care LLC | $130.42 | 2023 | Mirragen Advanced Wound Matrix |
| Restor3d, INC. | $129.60 | 2023 | |
| Aroa Biosurgery Incorporated | $126.34 | 2022 | |
| Cardiovascular Systems INC. | $114.99 | 2019 | |
| Abbott Laboratories | $112.43 | 2022-2023 | Absolute Pro |
| Medtronic, INC. | $88.86 | 2023-2024 | Closurefast, Turbohawk |
| Kerecis Limited | $76.35 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Averitas Pharma INC. | $69.34 | 2023 | Qutenza |
| Horizon Therapeutics Plc | $58.33 | 2020-2023 | Krystexxa |
| Embody, INC. | $57.32 | 2021 | |
| Treace Medical Concepts, INC. | $56.90 | 2023-2024 | |
| Csl Behring | $50.27 | 2022-2023 | Kcentra |
| Novastep INC. | $48.54 | 2022 | |
| Nevro Corp. | $45.21 | 2023 | Senza |
| Depuy Synthes Sales INC. | $44.92 | 2019-2024 | |
| Paratek Pharmaceuticals, INC. | $44.17 | 2021-2022 | |
| Reprise Biomedical, INC. | $30.34 | 2024 | Miro3d |
| Dynasplint Systems INC. | $28.02 | 2020 | |
| Innovation Technologies INC | $24.84 | 2022 | |
| Silk Road Medical, INC. | $24.43 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Grt US Holding, INC. | $23.65 | 2022 | |
| Solventum Corporation | $21.85 | 2024 | Activ.A.C. |
| Siemens Medical Solutions USA, INC. | $21.79 | 2023 | Magnetom Altea |
| Biotissue Holdings INC. | $21.55 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $20.18 | 2022 | |
| Alfasigma USA, INC. | $16.35 | 2021 | |
| Acera Surgical, INC. | $15.38 | 2022 | |
| Sebela Pharmaceuticals INC. | $14.34 | 2023 | Naftin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Hanna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.